C
CLB icon

Covestor’s Core Laboratories CLB Stock Holding History

Covestor’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Buy
18
+13
+260% +$186 ﹤0.01% 2515
2026
Q1 		$0 Hold
5
– – ﹤0.01% 2311
2025
Q4 		$0 Sell
5
-3
-38% -$45 ﹤0.01% 2309
2025
Q3 		$0 Buy
8
+3
+60% +$35 ﹤0.01% 2329
2025
Q2 		$0 Sell
5
-1
-17% -$12 ﹤0.01% 2260
2025
Q1 		$0 Buy
6
+1
+20% +$17 ﹤0.01% 2272
2024
Q4 		$0 Hold
5
– – ﹤0.01% 2280
2024
Q3 		$0 Hold
5
– – ﹤0.01% 2270
2024
Q2 		$0 Buy
+5
New +$88 ﹤0.01% 2281

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Covestor's CLB Position: Q2 2026 in Review

Covestor increased its Core Laboratories (CLB) stake by 260% in Q2 2026, buying an estimated $186 and bringing the position to 18 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2515.

Covestor first reported a position in CLB in Q2 2024 and has held it in 9 quarters since. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • Covestor held 18 shares of Core Laboratories worth $0 as of Q2 2026.
  • Covestor bought 13 Core Laboratories shares in Q2 2026, an estimated $186.
  • Core Laboratories made up ﹤0.01% of Covestor's portfolio in Q2 2026, its #2515 holding.
  • Covestor first reported a position in Core Laboratories in Q2 2024 and has held it in 9 quarters since.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.